Price data is not available
Iambic Therapeutics Inc (IAM) Stock Price, Quote, News & History
IAMNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Iambic Therapeutics (NASDAQ:IAM) through any online brokerage.
There are no as such competitors for Iambic Therapeutics.
There is no analysis for Iambic Therapeutics to provide a consensus price target.
The stock price for Iambic Therapeutics (NASDAQ: IAM) is $ last updated .
There are no upcoming dividends for Iambic Therapeutics.
Iambic Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Iambic Therapeutics.
Iambic Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.
